Vinva Investment Management Ltd Acquires Shares of 1,065 Align Technology, Inc. $ALGN

Vinva Investment Management Ltd acquired a new position in shares of Align Technology, Inc. (NASDAQ:ALGN) in the 2nd quarter, HoldingsChannel reports. The institutional investor acquired 1,065 shares of the medical equipment provider’s stock, valued at approximately $201,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Czech National Bank lifted its holdings in shares of Align Technology by 3.3% during the second quarter. Czech National Bank now owns 16,654 shares of the medical equipment provider’s stock worth $3,153,000 after purchasing an additional 537 shares during the period. QRG Capital Management Inc. bought a new position in Align Technology during the 2nd quarter worth $306,000. Envestnet Portfolio Solutions Inc. raised its position in Align Technology by 4.5% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 2,372 shares of the medical equipment provider’s stock worth $449,000 after purchasing an additional 102 shares during the last quarter. Navera Investment Management Ltd. lifted its holdings in Align Technology by 3.0% during the 2nd quarter. Navera Investment Management Ltd. now owns 787,559 shares of the medical equipment provider’s stock worth $149,126,000 after buying an additional 23,080 shares during the period. Finally, Acadian Asset Management LLC bought a new stake in shares of Align Technology in the 1st quarter valued at about $20,194,000. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Align Technology Stock Down 0.1%

Shares of NASDAQ:ALGN opened at $147.14 on Friday. The business’s 50 day moving average is $134.45 and its 200 day moving average is $156.42. Align Technology, Inc. has a 12-month low of $122.00 and a 12-month high of $246.19. The stock has a market cap of $10.56 billion, a price-to-earnings ratio of 28.51, a PEG ratio of 1.49 and a beta of 1.84.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings data on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.23. The business had revenue of $995.69 million for the quarter, compared to analysts’ expectations of $980.75 million. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.The business’s revenue was up 1.8% on a year-over-year basis. During the same period last year, the business earned $2.35 EPS. Align Technology has set its Q4 2025 guidance at EPS. As a group, equities research analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology declared that its board has initiated a stock repurchase plan on Tuesday, August 5th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the medical equipment provider to repurchase up to 2% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

Analyst Ratings Changes

ALGN has been the topic of a number of recent analyst reports. Weiss Ratings lowered Align Technology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, October 8th. Wall Street Zen upgraded shares of Align Technology from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. UBS Group reduced their price objective on shares of Align Technology from $160.00 to $155.00 and set a “neutral” rating on the stock in a research note on Thursday, October 16th. Morgan Stanley increased their price objective on shares of Align Technology from $142.00 to $154.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 30th. Finally, Evercore ISI lowered their target price on shares of Align Technology from $220.00 to $170.00 and set an “outperform” rating for the company in a research note on Tuesday, November 25th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Align Technology currently has an average rating of “Hold” and a consensus price target of $175.45.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.